Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Sevoflurane in Aortic Valve Replacement
NCT05864625Completed
- Sponsor
- Pusan National University Hospital
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in aortic stenosis (AS) (2 arms), sponsored by Pusan National University Hospital. Primary endpoint: Total dose of vasopressors and inotropics used. Started Jun 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT05864625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864625.